Dezerv

Fund Overview

Fund Size

Fund Size

₹694 Cr

Expense Ratio

Expense Ratio

2.37%

ISIN

ISIN

INF209KB1N91

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

11 Jul 2019

About this fund

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund schemes offered by Aditya Birla SL Mutual Fund. This fund has been in existence for 4 years, 10 months and 7 days, having been launched on 11-Jul-19.
As of 17-May-24, it has a Net Asset Value (NAV) of ₹26.61, Assets Under Management (AUM) of 694.50 Crores, and an expense ratio of 2.37%.
  • Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth has given a CAGR return of 22.23% since inception.
  • The fund's asset allocation comprises around 95.28% in equities, 0.00% in debts, and 4.72% in cash & cash equivalents.
  • You can start investing in Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth with a SIP of ₹1000 or a Lumpsum investment of ₹1000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+55.25%

+50.98% (Cat Avg.)

3 Years

+13.98%

+14.04% (Cat Avg.)

Since Inception

+22.23%

(Cat Avg.)

Portfolio Summaryas of 30th April 2024

Equity661.71 Cr95.28%
Others32.79 Cr4.72%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity103.08 Cr14.84%
Cipla LtdEquity54.37 Cr7.83%
Torrent Pharmaceuticals LtdEquity51.45 Cr7.41%
Apollo Hospitals Enterprise LtdEquity43.97 Cr6.33%
Clearing Corporation Of India LimitedCash - Repurchase Agreement33.78 Cr4.86%
Fortis Healthcare LtdEquity31.91 Cr4.59%
Zydus Lifesciences LtdEquity29.54 Cr4.25%
Ajanta Pharma LtdEquity28.89 Cr4.16%
Aurobindo Pharma LtdEquity27.83 Cr4.01%
Lupin LtdEquity27.03 Cr3.89%
Gland Pharma LtdEquity26.72 Cr3.85%
Alkem Laboratories LtdEquity24.05 Cr3.46%
Alembic Pharmaceuticals LtdEquity24.02 Cr3.46%
J.B. Chemicals & Pharmaceuticals LtdEquity23.42 Cr3.37%
Abbott India LtdEquity21.14 Cr3.04%
Dr Reddy's Laboratories LtdEquity19.73 Cr2.84%
Sanofi India LtdEquity19.11 Cr2.75%
Strides Pharma Science LtdEquity18.19 Cr2.62%
Jupiter Life Line Hospitals LtdEquity16.22 Cr2.34%
Vijaya Diagnostic Centre LtdEquity15.45 Cr2.23%
Star Health and Allied Insurance Co LtdEquity13.97 Cr2.01%
Mankind Pharma LtdEquity10.6 Cr1.53%
Medi Assist Healthcare Services LtdEquity7.32 Cr1.05%
Granules India LtdEquity6.25 Cr0.90%
Eris Lifesciences Ltd Registered ShsEquity5.96 Cr0.86%
Biocon LtdEquity4.44 Cr0.64%
Medplus Health Services LtdEquity3.95 Cr0.57%
Vinati Organics LtdEquity3.1 Cr0.45%
Net Receivables / (Payables)Cash-0.99 Cr0.14%

Allocation By Market Cap (Equity)

Large Cap Stocks

40.78%

Mid Cap Stocks

32.53%

Small Cap Stocks

21.97%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare644.63 Cr92.82%
Financial Services13.97 Cr2.01%
Basic Materials3.1 Cr0.45%

Risk & Performance Ratios

Standard Deviation

This fund

14.93%

Cat. avg.

14.57%

Lower the better

Sharpe Ratio

This fund

0.62

Cat. avg.

0.69

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

1.16

Higher the better

Fund Managers

DS

Dhaval Shah

Since July 2019

Dhaval Joshi

Dhaval Joshi

Since November 2022

Additional Scheme Detailsas of 30th April 2024

ISININF209KB1N91Expense Ratio2.37%Exit Load1.00%Fund Size₹694 CrAge11 Jul 2019Lumpsum Minimum₹1,000Fund StatusOpen Ended Investment CompanyBenchmarkS&P BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Withdrawal within 1 year

Flat 15% tax on realised gains (STCG - short term capital gains)

Withdrawal after 1 year

10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)

Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹13.07 Cr54.0%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.0%1.0%₹694.50 Cr57.4%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹694.50 Cr55.3%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹36.50 Cr52.9%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.4%1.0%₹161.86 Cr48.4%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹161.86 Cr45.4%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2236.01 Cr52.1%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

2.0%1.0%₹2236.01 Cr49.9%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹639.49 Cr53.9%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹16.41 Cr51.7%

About the AMC

Total AUM

₹3,44,491 Cr

Address

One World Centre, Tower 1, 17th Floor, Mumbai, 400 013

Other Funds by Aditya Birla SL Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
Aditya Birla Sun Life Fixed Maturity Plan-Series US (100 days) Direct Growth

Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Maturity Plan-Series UR (85 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Crisil IBX Gilt April 2033 Index Fund Direct Growth

Moderate Risk

0.2%0.0%₹91.81 Cr-
Aditya Birla Sun Life Fixed Maturity Plan-Series UQ (92 days) Direct Growth

Moderate Risk

-0.0%--
Aditya Birla Sun Life Transportation and Logistics Fund Direct Growth

Very High Risk

0.2%1.0%₹1295.47 Cr-
Aditya Birla Sun Life US Treasury 1-3 year Bond ETFs Fund of Funds Direct Growth

Very High Risk

0.2%0.0%₹84.87 Cr-
Aditya Birla Sun Life US Treasury 3-10 Year Bond ETFs Fund of Funds Direct Growth

Very High Risk

0.2%0.0%₹241.20 Cr-
Aditya Birla Sun Life Fixed Term Plan - Series SY (1259 days) Direct Growth

Low to Moderate Risk

----
Aditya Birla Sun Life Fixed Term Plan Series SP Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan - Series TV (1169 Days) Direct Growth

Moderate Risk

-0.0%--
Aditya BSL Fixed Term Plan Series SC(1170 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya BSL Fixed Term Plan Series SM Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series TN Direct Growth

Low to Moderate Risk

----
Aditya Birla Sun Life Fixed Term Plan - Series TL (1839 days) Direct Growth

Moderate Risk

-0.0%--
Aditya BSL Fixed Term Plan Series RM (91 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya BSL Fixed Term Plan Series SE(1163 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan - Series TM (1842 days) Direct Growth

Moderate Risk

----
Aditya Birla Sun Life Fixed Term Plan - Series TP (1923 Days) Direct Growth

Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan - Series TK (1833 days) Direct Growth

Moderate Risk

-0.0%--
Aditya BSL Fixed Term Plan Series RG(1283 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya BSL Fixed Term Plan Series SD(1168 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series TO (1214 days) Direct Growth

Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan - Series TE (1095 days) Direct Growth

Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan - Series TF (1098 days) Direct Growth

Moderate Risk

-0.0%--
Aditya BSL Fixed Term Plan SeriesSH (1146 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Interval Income Fund Quarterly Series I Direct Growth

Moderate Risk

-0.0%₹271.27 Cr7.5%
Aditya BSL Fixed Term Plan Series RZ(1187 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya BSL Fixed Term Plan Series SB(1174 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series TC (1119 days) Direct Growth

Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series UB (1224 Days) Direct Growth

Low to Moderate Risk

-0.0%-6.7%
Aditya Birla Sun Life Fixed Term Plan - Series TJ (1838 days) Direct Growth

Low to Moderate Risk

-0.0%₹23.88 Cr7.0%
Aditya Birla Sun Life Fixed Term Plan Series TI (1837 days) Direct Growth

Low to Moderate Risk

-0.0%₹290.41 Cr7.1%
Aditya Birla Sun Life Fixed Term Plan - Series TG (1099 days) Direct Growth

Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series TW (167 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series UC (95 days) Direct Growth

Low to Moderate Risk

----
Aditya Birla Sun Life Fixed Term Plan Series UF (180 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya BSL Fixed Term Plan Series RT (1223 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series SX Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan - Series TD (1100 days) Direct Growth

Moderate Risk

-0.0%--
Aditya BSL Fixed Term Plan Series TQ (1879 days) Direct Growth

Low to Moderate Risk

-0.0%₹201.28 Cr6.7%
Aditya Birla Sun Life Fixed Term Plan Series TH (1098 days) Direct Growth

Moderate Risk

-0.0%--
Aditya BSL Fixed Term Plan Series RS (1232 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series TU (1789 days) Direct Growth

Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series UD (79 days) Direct Growth

Low to Moderate Risk

----
Aditya Birla Sun Life Fixed Term Plan - Series UJ (1110 days) Direct Growth

Low to Moderate Risk

-0.0%-6.7%
Aditya Birla Sun Life Fixed Term Plan - Series UA (1231 days) Direct Growth

Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series SW Direct Growth

Low to Moderate Risk

----
Aditya BSL Fixed Term Plan Series QZ(1100 days) Direct Growth

Low to Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series UE (1275 days) Direct Growth

Moderate Risk

-0.0%--
Aditya Birla Sun Life Fixed Term Plan Series TB (1125 days) Direct Growth

Moderate Risk

-0.0%--

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, as of 17-May-2024, is ₹26.61.
The fund has generated 55.25% over the last 1 year and 13.98% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.
The fund's allocation of assets is distributed as 95.28% in equities, 0.00% in bonds, and 4.72% in cash and cash equivalents.
The fund managers responsible for Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth are:-
  1. Dhaval Shah
  2. Dhaval Joshi